🇨🇦 Amivantamab and Recombinant Human Hyaluronidase in Canada

Amivantamab and Recombinant Human Hyaluronidase (Amivantamab and Recombinant Human Hyaluronidase) regulatory status in Canada.

Marketing authorisation

Amivantamab and Recombinant Human Hyaluronidase in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Amivantamab and Recombinant Human Hyaluronidase approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Amivantamab and Recombinant Human Hyaluronidase in Canada?

National Cancer Institute (NCI) is the originator. The local marketing authorisation holder may differ — check the official source linked above.